+1 (561) 832 9277 icausa@icausa.org

2022 Fellowships

ICA USA has published the following list of Research Fellowships available for funding in 2022. 

Click this link to download a complete list of the 2022 fellowships available for funding.

For more information or individual fellowship abstracts please call ICA USA at 561-832-9277.

To have us contact you about funding a 2020 Fellowship, complete the Fellowship Inquiry Contact Form here.

2022 Research Grant Request Descriptions:

20220004 FUNDED
Dr. Amir Sonnenblick, Tel Aviv Sourasky Medical Center. The role of the ANXA1-ARID1A axis in luminal breast cancer. Funding Requested $22,000 

20220005 FUNDED
Dr.  Tomer Cooks, Ben Gurion University. DαRT and PSMA-targeting-nanobodies as a combination therapy for prostate cancer. Funding Requested $22,000

20220009 FUNDED
Prof. Jacob Moran-Gilad, Ben Gurion University. The anti-tumor activity in BRCA1-mutated ovarian cancer is derived by MHC-bound bacterial peptides and mediated by TRAF. Funding Requested $22,000 

20220010 FUNDED
Prof. Dan Levy, Ben Gurion University. Role of the methyltransferase SETD6 in melanoma progression. Funding Requested $22,000 

20220021 FUNDED
Prof. Michal Goldberg, Hebrew University. Regulation of FANCD2 and FANCI by UFMylation. Funding Requested $22,000

20220030 FUNDED
Prof. Itzhak Avital, Ben Gurion University. Targeting Cancer Stem Cells in Pancreatic Cancer: a personalized approach. Funding Requested $22,000

20220031 FUNDED
Dr. Shlomit Barzilai Birenboim, Schneider Children’s Medical Center of Israel. An international study of acute renal failure with severely delayed methotrexate elimination (DME) in children with acute lymphoblastic leukemia – the Ponto De Legno toxicity working group. Funding Requested $22,000

Prof. Rivka Dikstein, Weizmann Institute of Science. Alternative promoter usage in chronic lymphocytic leukemia and its microenvironment: oncogenic potential, vulnerabilities and therapeutic targets. Funding Requested $22,000

20220035 FUNDED
Prof. Dalit Modan, Sheba Medical Center. Cognitive functioning, learning and memory in survivors of childhood cancer. Funding Requested $22,000

Dr. Gabi Gerlitz, Ariel University. A new function for the oncogene SETDB1 in regulation of microtubule dynamics. Funding Requested $22,000

20220039 FUNDED
Prof. Adit Ben-Baruch, Tel Aviv University. The balance between TNFR2+ TIL subsets in triple-negative breast tumors, and its impact on disease course. Funding Requested $22,000

Prof. Nilly Mor, Hebrew University. The relationship between cognitive biases and psychopathology among children with cancer and their parents. Funding Requested $22,000

Dr. Rinat Ernstein-Molho, Sheba Medical Center. Genomic determinants of age at diagnosis of breast cancer in BRCA1 mutation carriers. Funding Requested $22,000

20220054 FUNDED
Dr. Bat Chen Revital Lubin, Eastern R&D Center. Novel peptides for targeted drug delivery for the treatment of non-small-cell lung cancer. Funding Requested 22,000 $

Prof. Tal Burstyn-Cohen, Hebrew University. Mechanistic insights into the anti-metastatic properties of PROS1 in myeloid cells. Funding Requested $22,000

Prof. Yori Gidron, Haifa University. Effects of vagal nerve biofeedback on neuroimmunological and oncological outcomes in advanced pancreatic cancer: Psycho-oncology is not vague. Funding Requested $22,000

Dr. Shahar Alon, Bar Ilan University. Characterizing immune-tumor interactions using expansion sequencing. Funding Requested $22,000

20220081 FUNDED
Dr. Arnon Haran, Hadassah Ein Kerem Medical Center. Methionine metabolism in acute myeloid leukemia. Funding Requested $22,000

Dr. Yaakov Maman, Bar Ilan University. dNTP depletion as a major determinant of Helicobacter pylori oncogenicity. Implications on Gastric Cancer etiology and predisposition. Funding Requested $22,000

20220098 FUNDED
Prof. Carmit Levy, Tel Aviv University . Physical activity generates metabolic shield in internal organs: Novel concept in the prevention and treatment of cancer. Funding Requested $22,000

20220099 FUNDED
Prof. Mordechay (Motti) Gerlic, Tel Aviv University. Harnessing necroptotic cell death to induce an anti-tumor immunity. Funding Requested $22,000

20220100 FUNDED
Dr. Omer Murik, Shaare Zedek Medical Center. Personalized genome-wide transcriptional profiling of mammary epithelial cells from healthy patients carrying BRCA1/2 mutations. Funding Requested $22,000

Dr. Eitan Shaulian, Hebrew University. Analysis of proteins mediating the transcriptional effects of JUNI. Funding Requested $22,000

Dr./Prof. Shmuel Cohen, Nir Lubezky Tel Aviv Medical Center. Effect of intra-gastric microbiota administration on liver immunity and progression of colorectal liver metastases after liver resection. Funding Requested $22,000

Dr. Ilan Volovitz, Tel Aviv Sourasky Medical Center. Identification of cancer-specific promoters or human glioblastoma using synthetic biology. Funding Requested $22,000

20220107 FUNDED
Dr. Hadar Zigdon Giladi, Rambam Medical Center. Investigating the synergistic effect of VEGFA and FGF2 on osteosarcoma aggressiveness. Funding Requested $22,000

Dr. Ofir Hakim, Bar Ilan University. Dissecting the interplay between p53 and Fra-1transcription factors in carcinogenesis. Funding Requested $22,000

20220114 FUNDED
Dr. Eyal Lebel, Hadassah Ein Kerem Medical Center. Tracking clonal evolution in multiple myeloma with circulating tumor DNA. Funding Requested $22,000

Prof. Daniel Kornik, Rambam Medical Center. Reducing vincristine neurotoxicity in children with cancer: Is isavuconazole a safer alternative to strongly CYP3A4-inhibiting azole antifungals? Funding Requested $22,000

Prof. Rachel Grossman, Tel Aviv Sourasky Medical Center. Language preservation during glioma awake craniotomy: Continuous dynamic stimulation technique to assess the language pathways. Funding Requested $22,000

Dr. Rotem Lapidot, Rambam Medical Center. Nasopharyngeal and Oral Microbiome and its association with the development of mucositis in pediatric oncology patients. Funding Requested $22,000

Prof. Zohar Levi, Rabin Medical Center. Risk of malignancy and factors associated with occurrence among the Israeli Inflammatory Bowel Disease cohort (EPI-RNII): a population-based, case-control and nested case-control study and development of a Personalized risk score prediction model. Funding Requested $22,000

Dr. Barak Rotblat, Ben Gurion University. Mitochondrial chaperones supporting metabolic reprogramming in glioblastoma. Funding Requested $22,000

20220145 FUNDED
Dr. Amit Tirosh, Sheba Medical Center. Hypoxic onco-metabolic drivers in entero-pancreatic neuroendocrine tumors. Funding Requested $22,000

For more information on fellowship funding please call our office at (561) 832-9277.